Immune system study for diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the immune system works in people with diabetic kidney disease. It tests whether certain blood pressure medicines can help protect the kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is below 30
- You have not had any major blood vessel problems (like heart attack, stroke, or leg artery disease)
- You are taking a high dose of an ACE inhibitor or ARB medicine for blood pressure
- You do not have a BMI of 30 or above
- You have no known blockages in your large arteries
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with diabetic kidney disease engage with their care. It may help find ways to better support patients, though it does not test a new treatment.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study looks at how the bacteria in your gut and certain blood markers might help predict changes in blood sugar levels for people with type 2 diabetes and kidney disease. The findings could lead to better ways to manage your condition and prevent complications.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This study tests whether a new care plan for people with diabetes and kidney disease can reduce the risk of serious heart and kidney events. It aims to improve outcomes by closely following patients in routine care.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.